ProPhase Labs, Inc. (PRPH) Return on equity 2016–2025
ProPhase Labs, Inc. (PRPH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-420.3%FY2025 · since FY2016: -48.1% → -420.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -420.3% | +305.5 pp |
| FY2024 | -725.7% | -691.8 pp |
| FY2023 | -34.0% | -63.0 pp |
| FY2022 | 29.0% | +18.3 pp |
| FY2021 | 10.7% | +30.8 pp |
| FY2020 | -20.1% | +7.9 pp |
| FY2019 | -28.0% | -17.5 pp |
| FY2018 | -10.5% | -138.0 pp |
| FY2017 | 127.4% | +175.6 pp |
| FY2016 | -48.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice